Variable degree of Growth Hormone (GH) and Insulin-like Growth Factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: Evidence from an IGF-based dosing study of short children

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2089-2098

  Cohen, Pinchas ^a   Germak, John ^b   Rogol, Alan D ^c,d   Weng, Wayne ^b   Kappelgaard, Anne Marie ^e   Rosenfeld, Ron G ^f  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b NOVO NORDISK INC   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e NOVO NORDISK A S   (Denmark)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CHILD; CHILD GROWTH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG RESPONSE; DRUG TARGETING; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT STATURE; BLOOD; BODY HEIGHT; BODY MASS; BREAST; DRUG EFFECT; GROWTH; HISTOLOGY; METABOLISM; PHYSIOLOGY; PITUITARY DWARFISM; PRESCHOOL CHILD; TESTIS;

BODY HEIGHT; BODY MASS INDEX; BREAST; CHILD; CHILD, PRESCHOOL; DWARFISM, PITUITARY; FEMALE; GROWTH; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; SOMATOMEDINS; TESTIS;

EID: 77952766080     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2139     Document Type: Article

References (30)

1. Frasier SD, Costin G, Lippe BM, Aceto Jr T, Bunger PF 1981 A dose-response curve for human growth hormone. J Clin Endocrinol Metab 53:1213-1217 (Pubitemid 13237556)
2. de Muinck Keizer-Schrama SM, Rikken B, Wynne HJ, Hokken-Koelega AC, Wit JM, Bot A, Drop SL 1992 Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group. J Clin Endocrinol Metab 74: 898-905
3. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J 2000 High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 85:3653-3660
4. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG 2002 Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: Implications for efficacy and safety. J Clin Endocrinol Metab 87:90-98
5. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG 2008 Height velocity targets from NCGS for first year growth hormone responses in short children. J Clin Endocrinol Metab 93:352-357
6. Kaplan SA, Cohen P 2007 The somatomedin hypothesis 2007: fifty years later. J Clin Endocrinol Metab 92:4529-4535
7. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
8. Cohen P 2006 Overview of the IGF-I system. Horm Res 65(Suppl 1):S3-S8
9. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363-1367
10. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P 2008 Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res 18:89-110
11. Rosenfeld RG 2005 The molecular basis of idiopathic short stature. Growth Horm IGF Res 15(Suppl A):S3-S5
12. Wilson DM, Frane J 2005 A brief review of the use and utility of growth hormone stimulation testing in the NCGS: do we need to do provocative GH testing? Growth Horm IGF Res 15(Suppl A):S21-S25
13. Bidlingmaier M, Freda PU 2010 Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res 20:19-25
14. Frystyk J, Freda P, Clemmons DR 2009 The current status of IGF-I assays - a 2009 update. Growth Horm IGF Res 20:8-18
15. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG 2007 Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
16. World Medical Association 1997 declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277:925-926
17. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
18. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
19. Greulich W, Pyle S 1959 Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press
20. Keni J, Cohen P 2009 Optimizing growth hormone dosing in children with idiopathic short stature. Horm Res 71(Suppl 1):S70-S74
21. Toyoshima MT, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ, Jorge AA 2007 Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clin Endocrinol (Oxf) 67:500-504
22. DosSantos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougnères P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
23. Hernández MI, Cohen P 2008 Surprising new height regulating genes: beyond growth hormone and IGF-I. Pediatr Res 64:461
24. Visscher PM 2008 Sizing up human height variation. Nat Genet 40:489-490
25. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO 2007 KIGS International Board. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Horm Res 68:53-62
26. Bright GM, Julius JR, Lima J, Blethen SL 1999 Growth hormone stimulation test results as predictors of recombinant human growth hormone treatment outcomes: preliminary analysis of the national cooperative growth study database. Pediatrics 104(4 Pt 2):1028-1031 (Pubitemid 29463546)
27. Geffner ME, Dunger DB 2007 Future directions: growth prediction models. Horm Res 68(Suppl 5):S51-S56
28. Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K 2009 Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. J Clin Endocrinol Metab 94:483-490
29. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM on behalf of the 2007 ISS Consensus Workshop participants 2008 Consensus Guidelines for the diagnosis and treatment of children with idiopathic short stature: a summary statement of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 93: 4210-4217
30. Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, Cassorla FG, Quigley CA, Crowe BJ, Roberts K, Cutler Jr GB 2004 Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab 89:4873-4878